HomeCompareDJPY vs JNJ

DJPY vs JNJ: Dividend Comparison 2026

DJPY yields 10.33% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DJPY wins by $19.6K in total portfolio value
10 years
DJPY
DJPY
● Live price
10.33%
Share price
$19.37
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.6K
Annual income
$1,974.09
Full DJPY calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DJPY vs JNJ

📍 DJPY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDJPYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DJPY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DJPY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DJPY
Annual income on $10K today (after 15% tax)
$877.65/yr
After 10yr DRIP, annual income (after tax)
$1,677.98/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, DJPY beats the other by $974.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DJPY + JNJ for your $10,000?

DJPY: 50%JNJ: 50%
100% JNJ50/50100% DJPY
Portfolio after 10yr
$29.8K
Annual income
$1,400.93/yr
Blended yield
4.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DJPY
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DJPY buys
0
JNJ buys
0
No recent congressional trades found for DJPY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDJPYJNJ
Forward yield10.33%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$39.6K$20.0K
Annual income after 10y$1,974.09$827.78
Total dividends collected$15.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DJPY vs JNJ ($10,000, DRIP)

YearDJPY PortfolioDJPY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,733$1,032.52$10,676$355.77+$1.1KDJPY
2$13,686$1,132.16$11,407$389.39+$2.3KDJPY
3$15,878$1,234.26$12,198$426.53+$3.7KDJPY
4$18,328$1,338.29$13,056$467.62+$5.3KDJPY
5$21,055$1,443.71$13,987$513.12+$7.1KDJPY
6$24,079$1,549.99$14,998$563.56+$9.1KDJPY
7$27,421$1,656.64$16,098$619.52+$11.3KDJPY
8$31,103$1,763.16$17,295$681.69+$13.8KDJPY
9$35,150$1,869.11$18,599$750.82+$16.6KDJPY
10$39,584$1,974.09$20,022$827.78+$19.6KDJPY

DJPY vs JNJ: Complete Analysis 2026

DJPYStock

The investment seeks to track the daily performance of the VelocityShares Daily 4X Long USD vs. JPY Index. The index is designed to provide 4 times leveraged exposure, reset daily, to changes in the spot exchange rate between an underlying pair of currencies consisting of the U.S. dollar and a foreign currency. It provides long exposure to one currency (the "long currency") in the underlying currency pair relative to the other currency (the "reference currency"). The fund is non-diversified.

Full DJPY Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DJPY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DJPY vs SCHDDJPY vs JEPIDJPY vs ODJPY vs KODJPY vs MAINDJPY vs ABBVDJPY vs MRKDJPY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.